blog

Pharma15 Live! Director’s Chair

By Aaron Fleishman on Fri, Jul 17, 2020 | 3 min read

 

As the director and one of the producers of Pharma15 Live! I wanted to share with you some insights into what we’ve learned through an amazing three seasons! First of all, if you were to tell me at the beginning of our series that it would even last three seasons, I’d tell you I’d be shocked – but nonetheless here we are and it’s been great!

Topics: Pharma15 Live!, COVID-19, Matt Kibby, Aaron Fleishman, Craig Lipset, Advarra, Season Three, Michele Russell-Einhorn, Dan Sfera, Ray Dorsey, MD

The Impact of COVID-19 on Clinical Trials: Where Are We? And Where Are We Going?

By Aaron Fleishman, Director, Market Development on Tue, Jun 23, 2020 | 2 min read

As the country goes through the phases of reopening, what does that mean for the patient and site experience in clinical trials? PharmaTalkRadio’s Valerie Bowling discusses the future of clinical trials with Ray Dorsey, MD, Matt Kibby, and Craig Lipset in this feature podcast.

Topics: Clinical Trials, Pharma15 Live!, COVID-19, Matt Kibby, Craig Lipset, Decentralized Trials, Conference Forum

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

By Elizabeth Gargill on Thu, Apr 23, 2020 | 1 min read

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

 
Subscribe To Our Blog